P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study. Subrata G, Geert D, Vipul J, Florian R, et al. Am J Gastroenterol 2020;115.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Subrata G, Geert D, Vipul J, Florian R, et al. P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study. Am J Gastroenterol 2020;115.
PMID: 33566486